nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiviral activity of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) against hepatitis B virus
|
Huang, Quanfang |
|
2013 |
100 |
2 |
p. 373-381 9 p. |
artikel |
2 |
A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus – An emerging rhabdovirus
|
Roy, Arunava |
|
2013 |
100 |
2 |
p. 346-355 10 p. |
artikel |
3 |
Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus
|
Bhomia, Manish |
|
2013 |
100 |
2 |
p. 429-434 6 p. |
artikel |
4 |
Baseline sensitivity of HSV-1 and HSV-2 clinical isolates and defined acyclovir-resistant strains to the helicase–primase inhibitor pritelivir
|
Field, Hugh J. |
|
2013 |
100 |
2 |
p. 297-299 3 p. |
artikel |
5 |
Clinical management and infection control of SARS: Lessons learned
|
Cheng, Vincent C.C. |
|
2013 |
100 |
2 |
p. 407-419 13 p. |
artikel |
6 |
Construction and characterisation of replicating foamy viral vectors expressing HIV-1 epitopes recognised by broadly neutralising antibodies
|
Mühle, Michael |
|
2013 |
100 |
2 |
p. 314-320 7 p. |
artikel |
7 |
Development and characterization of a replicon-based phenotypic assay for assessing HCV NS4B from clinical isolates
|
Rajyaguru, Sonal |
|
2013 |
100 |
2 |
p. 328-336 9 p. |
artikel |
8 |
Differential gene expression in HIV-infected individuals following ART
|
Massanella, Marta |
|
2013 |
100 |
2 |
p. 420-428 9 p. |
artikel |
9 |
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
|
Furuta, Yousuke |
|
2013 |
100 |
2 |
p. 446-454 9 p. |
artikel |
10 |
Host-targeting agents in the treatment of hepatitis C: A beginning and an end?
|
Baugh, James M. |
|
2013 |
100 |
2 |
p. 555-561 7 p. |
artikel |
11 |
Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection
|
Reitsma, Justin M. |
|
2013 |
100 |
2 |
p. 321-327 7 p. |
artikel |
12 |
Inhibition of hepatitis C virus infection by polyoxometalates
|
Qi, Yue |
|
2013 |
100 |
2 |
p. 392-398 7 p. |
artikel |
13 |
Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry
|
Nasser, Zainab H. |
|
2013 |
100 |
2 |
p. 399-406 8 p. |
artikel |
14 |
Inhibition of influenza virus internalization by (−)-epigallocatechin-3-gallate
|
Kim, Meehyein |
|
2013 |
100 |
2 |
p. 460-472 13 p. |
artikel |
15 |
Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model
|
Jones, B.G. |
|
2013 |
100 |
2 |
p. 562-566 5 p. |
artikel |
16 |
Inside Back Cover: Notes to Authors
|
|
|
2013 |
100 |
2 |
p. IBC- 1 p. |
artikel |
17 |
Insights from host genomics into HIV infection and disease: Identification of host targets for drug development
|
Ballana, Ester |
|
2013 |
100 |
2 |
p. 473-486 14 p. |
artikel |
18 |
Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations
|
Pan, Peichen |
|
2013 |
100 |
2 |
p. 356-364 9 p. |
artikel |
19 |
In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons
|
Yu, Mei |
|
2013 |
100 |
2 |
p. 439-445 7 p. |
artikel |
20 |
Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance
|
Burnham, Andrew J. |
|
2013 |
100 |
2 |
p. 520-534 15 p. |
artikel |
21 |
Neurological approaches for investigating West Nile virus disease and its treatment in rodents
|
Morrey, John D. |
|
2013 |
100 |
2 |
p. 535-545 11 p. |
artikel |
22 |
Phenotypic and genotypic characterization of induced acyclovir-resistant clinical isolates of herpes simplex virus type 1
|
Hussin, Ainulkhir |
|
2013 |
100 |
2 |
p. 306-313 8 p. |
artikel |
23 |
PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3
|
Li, Rui |
|
2013 |
100 |
2 |
p. 546-554 9 p. |
artikel |
24 |
Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: An Indian perspective
|
Srivastava, Manjita |
|
2013 |
100 |
2 |
p. 300-305 6 p. |
artikel |
25 |
Prelim II: Editorial Board
|
|
|
2013 |
100 |
2 |
p. ii- 1 p. |
artikel |
26 |
Selection and characterization of viruses resistant to the dual acting pyrimidinedione entry and non-nucleoside reverse transcriptase inhibitor IQP-0410
|
Buckheit Jr., Robert W. |
|
2013 |
100 |
2 |
p. 382-391 10 p. |
artikel |
27 |
Single-stranded DNA aptamer that specifically binds to the influenza virus NS1 protein suppresses interferon antagonism
|
Woo, Hye-Min |
|
2013 |
100 |
2 |
p. 337-345 9 p. |
artikel |
28 |
Strategic use of lamivudine in the management of chronic hepatitis B
|
Soriano, Vincent |
|
2013 |
100 |
2 |
p. 435-438 4 p. |
artikel |
29 |
Surveillance of herpes simplex virus resistance to antivirals: A 4-year survey
|
Burrel, Sonia |
|
2013 |
100 |
2 |
p. 365-372 8 p. |
artikel |
30 |
Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice
|
Shestakov, Andrey |
|
2013 |
100 |
2 |
p. 455-459 5 p. |
artikel |
31 |
Ten years of dengue drug discovery: Progress and prospects
|
Lim, Siew Pheng |
|
2013 |
100 |
2 |
p. 500-519 20 p. |
artikel |
32 |
The DEAD-box RNA helicase DDX5 acts as a positive regulator of Japanese encephalitis virus replication by binding to viral 3′ UTR
|
Li, Chen |
|
2013 |
100 |
2 |
p. 487-499 13 p. |
artikel |
33 |
Universal anti-neuraminidase antibody inhibiting all influenza A subtypes
|
Doyle, Tracey M. |
|
2013 |
100 |
2 |
p. 567-574 8 p. |
artikel |